Physician profile
Grace Wang
NPI 1104365303
$2,437.10
in general payments reported to CMS, 2019-2025
15 companies · $620 in 2025
The $620 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $535 · 2022: $521 · 2023: $259 · 2024: $503 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $731.34 | 2021-2025 | |
| Gilead Sciences, INC. | $717.03 | 2021-2025 | Livdelzi |
| Madrigal Pharmaceuticals | $291.62 | 2024-2025 | Rezdiffra |
| W. L. Gore & Associates, INC. | $159.53 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Lilly USA, LLC | $116.33 | 2021-2022 | |
| Amgen INC. | $71.72 | 2021-2022 | |
| Amarin Pharma, INC. | $68.44 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $58.62 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.16 | 2021 | |
| Novo Nordisk INC | $44.87 | 2022 | |
| Merck Sharp & Dohme LLC | $34.85 | 2021-2022 | |
| Redhill Biopharma INC. | $34.55 | 2021-2022 | |
| Vivus LLC | $23.82 | 2021 | |
| Dexcom, INC. | $20.03 | 2023 | Dexcom G6 Transmitter |
| Braintree Laboratories, INC. | $17.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.